FDA approval count fell last year, despite a steady regulatory filing rate.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Development and application of a high-content virion display human GPCR array
Nature Communications Open Access 30 April 2019
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Mullard, A. 2016 FDA drug approvals. Nat Rev Drug Discov 16, 73–76 (2017). https://doi.org/10.1038/nrd.2017.14
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd.2017.14
This article is cited by
-
Synthesis and dopamine receptor binding of dihydrexidine and SKF 38393 catecholamine-based analogues
Amino Acids (2022)
-
Trends in PhysChem Properties of Newly Approved Drugs over the Last Six Years; Predicting Solubility of Drugs Approved in 2021
Journal of Solution Chemistry (2022)
-
Predicting Solubility of Newly-Approved Drugs (2016–2020) with a Simple ABSOLV and GSE(Flexible-Acceptor) Consensus Model Outperforming Random Forest Regression
Journal of Solution Chemistry (2022)
-
Life sciences intellectual property licensing at the Massachusetts Institute of Technology
Nature Biotechnology (2021)
-
Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases
Nature Reviews Rheumatology (2020)